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Abstract
Salmonella enterica serotype Kentucky can be a common causative agent of salmonellosis, usually associated with consump-
tion of contaminated poultry. Antimicrobial resistance (AMR) to multiple drugs, including ciprofloxacin, is an emerging problem 
within this serotype. We used whole-genome sequencing (WGS) to investigate the phylogenetic structure and AMR content of 
121 S. enterica serotype Kentucky sequence type 198 isolates from five continents. Population structure was inferred using 
phylogenomic analysis and whole genomes were compared to investigate changes in gene content, with a focus on acquired 
AMR genes. Our analysis showed that multidrug-resistant (MDR) S. enterica serotype Kentucky isolates belonged to a single 
lineage, which we estimate emerged circa 1989 following the acquisition of the AMR-associated Salmonella genomic island 
(SGI) 1 (variant SGI1-K) conferring resistance to ampicillin, streptomycin, gentamicin, sulfamethoxazole and tetracycline. Phylo-
geographical analysis indicates this clone emerged in Egypt before disseminating into Northern, Southern and Western Africa, 
then to the Middle East, Asia and the European Union. The MDR clone has since accumulated various substitution mutations 
in the quinolone-resistance-determining regions (QRDRs) of DNA gyrase (gyrA) and DNA topoisomerase IV (parC), such that 
most strains carry three QRDR mutations which together confer resistance to ciprofloxacin. The majority of AMR genes in the 
S. enterica serotype Kentucky genomes were carried either on plasmids or SGI structures. Remarkably, each genome of the MDR 
clone carried a different SGI1-K derivative structure; this variation could be attributed to IS26-mediated insertions and dele-
tions, which appear to have hampered previous attempts to trace the clone’s evolution using sub-WGS resolution approaches. 
Several different AMR plasmids were also identified, encoding resistance to chloramphenicol, third-generation cephalosporins, 
carbapenems and/or azithromycin. These results indicate that most MDR S. enterica serotype Kentucky circulating globally 
result from the clonal expansion of a single lineage that acquired chromosomal AMR genes 30 years ago, and has continued to 
diversify and accumulate additional resistances to last-line oral antimicrobials. This article contains data hosted by Microreact.
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DATA SummARy
All sequencing reads generated in this study have been 
deposited in the European Nucleotide Archive (ENA) (http://
www. ebi. ac. uk/ ena) under project number PRJNA445436. 
SRA accession numbers can be found in Table S1 (available 
in the online version of this article). The reference genome 
sequence for Salmonella enterica serotype Kentucky strain 
201001922 has been deposited in GenBank under accession 
number CP028357. The phylogeny and associated metadata 
can be viewed on Microreact: https:// microreact. org/ project/ 
Hkl7CzEXV.
InTRoDuCTIon
Carbapenem-resistant, extended-spectrum β-lactamase 
(ESBL) producing Enterobacteriaceae and fluoroquinolone-
resistant Salmonella have been recently listed as priority 
pathogens that pose the greatest threats to human health 
(critical and high threat levels, respectively) by the World 
Health Organization (WHO) [1]. All these resistances have 
been observed in a single serotype of Salmonella enterica, 
serotype Kentucky, since the 2000s [2–5]. Ciprofloxacin-
resistant (CIPR) S. enterica serotype Kentucky was first 
observed in a French traveller returning from Egypt in 
2002, before being increasingly isolated globally [2]. 
Between 2007 and 2012, the European Centers for Disease 
Control and Prevention (ECDC) reported 1301 isolations of 
S. enterica serotype Kentucky from 12 countries, including 955 
(73.4 %) CIPR S. enterica serotype Kentucky [6]. These isolates 
were found in patients across the world, but predominantly 
in Northern Africa, Europe and Southern Asia. Several 
previous studies have described the rapid spread of CIPR 
S. enterica serotype Kentucky from Northern Africa to the rest 
of the African continent, as well as the Middle East, Europe 
and Asia [3–5]. CIPR S. enterica serotype Kentucky is a food-
borne pathogen that causes gastroenteritis in humans, and 
domestic poultry has played an important role in its global 
spread (most recently in South Asia and Europe). Multilocus 
sequence typing (MLST) and PFGE have revealed that CIPR 
S. enterica serotype Kentucky is a single population belonging 
to sequence type (ST)198 and not ST152, which is a prevalent 
S. enterica serotype Kentucky ST found in poultry in the USA 
but rarely reported in humans [7].
Before the 1990s, S. enterica serotype Kentucky ST198 was 
susceptible to all antibiotics. Since then, multidrug resist-
ance has emerged [2]. In the early 1990s, S. enterica sero-
type Kentucky ST198 acquired a variant of the Salmonella 
genomic island (SGI) 1 in the chromosome, likely in Egypt 
[8]. Initially characterized in S. enterica serotype Typhimu-
rium strain DT104 [9], the SGI1 is a site-specific integrative 
mobilizable element (IME) that integrates in the 3′-end of the 
conserved chromosomal gene trmE [10]. SGI1 is the proto-
type element of a multidrug resistance IME family named 
SGI/PGI/AGI, which includes both Proteus genomic islands 
(PGIs) [11] and Acinetobacter genomic islands (AGIs) [12]. 
They consist of a 27 kbp related backbone with conserved 
gene synteny and variable regions containing complex 
class 1 integron structures, insertion sequences and trans-
poson elements that are responsible for multidrug resistance. 
As an IME, SGI1 is specifically mobilized in trans by conjuga-
tive IncC plasmids [13–15]. The most recent findings revealed 
complex interactions between SGI1 and IncC plasmids for 
transfer and maintenance. Since the first description of SGI1 
in S. enterica serotype Typhimurium DT104, several variants 
of SGI/PGI/AGI have been discovered, which differ in their 
antimicrobial resistance (AMR) gene content and AMR gene 
cluster structure [16, 17] in species of families Enterobacte-
riaceae and Morganellaceae, and Acinetobacter baumannii 
[12, 18]. These variants usually differ in the composition of 
the integron, and each variant carries different AMR genes. 
One variant of the SGI, known as SGI2 or SGI1-J, differs not 
only in the composition of the integron, but also in the site at 
which the integron is inserted into the SGI backbone [8, 19].
ImPACT STATEmEnT
Fluoroquinolone-resistant Salmonella enterica and 
carbapenem-resistant, extended-spectrum β-lactamase 
producing Enterobacteriaceae are amongst the highest 
priority pathogens posing a risk to human health as 
determined by the World Health Organization (WHO). All 
of these high level resistances have been detected in a 
single serotype of S. enterica, serotype Kentucky, against 
a background of multidrug resistance to first-line antimi-
crobials, leaving very limited treatment options. Here, we 
analysed the genomes of S. enterica serotype Kentucky 
from geographically diverse sources, to investigate the 
emergence and spread of antibiotic resistance in this 
problem pathogen. We discovered that the multidrug-
resistant (MDR) genomes in our collection comprised a 
clonal MDR lineage that we estimate arose in Egypt in 
~1989, before spreading across Africa, then into Europe, 
the Middle East and Asia. Resistance to first-line antibi-
otics mostly arose from the chromosomal integration of 
a large genomic island, the Salmonella genomic island 
1, in the common ancestor of the MDR lineage. Most 
strains were also fluoroquinolone resistant, due to acqui-
sition of point mutations in chromosomal genes gyrA 
and parC early in the clone’s evolution. Additional resist-
ances, including to third-generation cephalosporins 
(such as ceftriaxone), carbapenems (such as imipenem) 
and the last-line oral antibiotic azithromycin, emerged 
through acquisition of diverse locally circulating MDR 
plasmids. Aside from antibiotic resistance, we found no 
other genetic determinants that could explain the global 
success of this S. enterica serotype Kentucky lineage. 
These data show the MDR clone of S. enterica sero-
type Kentucky is already widespread and is capable of 
acquiring last-line resistances, suggesting it should be 
considered a high-risk global MDR clone.
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Four main types of SGI have so far been described in 
S. enterica serotype Kentucky: SGI1-K, SGI1-P, SGI1-Q and 
SGI2 [4]. These SGI1 variants share a common genetic feature 
consisting of an insertion/deletion between S005 and S009 
due to the insertion of IS1359, which was also found in a 
few other SGI1 variants in strains of different S. enterica 
serotypes isolated in 2000 in Egypt, and more recently in 
Proteus mirabilis [20]. Additionally, these three SGI1 variants 
show a truncation at the 5′-end of S044, the final ORF of the 
SGI backbone, through the insertion of IS26 [21]. SGI1-K 
contains a complex mosaic resistance region made of different 
segments of transposons Tn21, Tn1721, Tn5393, Tn3-like and 
a In4-type integron structure, as well as IS26 elements [22]. 
SGI1-P and SGI1-Q contain only the IS26-flanked Tn3-like 
structure carrying blaTEM-1 and only the rightmost IS26 in 
S044, respectively [21].
After the acquisition of SGI1 by the multidrug-resistant 
(MDR) lineage, high level-resistance to fluoroquinolones 
emerged, conferred by a combination of three amino-acid 
substitutions in the quinolone-resistance-determining region 
(QRDR) of gyrA and parC. Previous epidemiological studies 
determined that these mutations likely arose in Egypt in the 
early 2000s [3].
Finally, additional resistance was gained through the acquisition 
of locally circulating plasmid-borne ESBL, AmpC and/or carbap-
enemase genes [4]. Additionally, the geographical distribution of 
CIPR S. enterica serotype Kentucky ST198 overlaps with other 
highly drug resistant Enterobacteriaceae carrying plasmid-borne 
ESBL, AmpC and/or carbapenemase genes, leading to predic-
tions that highly-drug resistant S. enterica serotype Kentucky 
ST198 strains are likely to become more frequent in the near 
future due to novel plasmid acquisitions [4, 5].
To date, all previous studies have used conventional typing 
methods [MLST, PCR, PFGE and antimicrobial susceptibility 
testing (AST)] and together they suggest that the recent global 
spread of CIPR S. enterica serotype Kentucky may reflect the 
expansion of a single clone, driven by the emergence of AMR. 
However, the precise nature, order and timing of the evolu-
tionary events underlying this overall picture, remain unclear. 
Here, we investigated the global population structure of MDR 
S. enterica serotype Kentucky ST198 using whole-genome 
sequencing (WGS) and phylogenomic analysis to interrogate 
a collection of 121 human and non-human isolates collected 
from 33 countries on five continents, between 1937 and 2016. 
We used comparative genomics to reconstruct the various 
steps in the acquisition of AMR determinants within the 
emerging MDR S. enterica serotype Kentucky ST198 clone, 
and to investigate the presence of genetic elements not related 
to AMR that might have conferred other selective advantages 
to this emerging bacterial pathogen.
mETHoDS
Bacterial isolates used in this study
A total of 97 S. enterica serotype Kentucky ST198 isolates 
were directly analysed in this study (Table S1), including 68 
isolates collected between 1937 and 2013 that were previously 
studied by conventional molecular methods [3–5, 23], and 29 
new isolates collected between 2008 and 2016. These isolates 
originated from the French National Reference Center for 
Escherichia coli, Shigella, Salmonella (Institut Pasteur) and 
several other international laboratories, and were selected 
on the basis of their diversity (human or non-human source, 
geographical area and year of isolation, PFGE types, and 
AMR phenotypes and genotypes). WGS data for a further 24 
S. enterica serotype Kentucky isolates was included in genomic 
analyses as detailed below.
AST
AST was performed on all 97 S. enterica serotype Kentucky 
ST198 isolates using the disc diffusion method with a 
panel of 32 antimicrobial agents (Bio-Rad), as described 
previously [24]. The minimum inhibitory concentrations 
(MICs) of ceftriaxone, ceftazidime, imipenem, ertapenem, 
meropenem, ciprofloxacin, azithromycin and tigecycline 
were also determined by Etests (AB Biodisk). Results were 
interpreted with the Antibiogram Committee of the French 
Society for Microbiology/European Committee on Antimi-
crobial Susceptibility Testing (CA-SFM/EUCAST) ( www. 
sfm- microbiologie. org/) breakpoints. In particular, we used 
ciprofloxacin clinical breakpoints defined for intestinal 
Salmonella isolates: susceptible when MIC≤0.25 mg l−1, and 
resistant when MIC>0.5 mg l−1.
WGS
The 97 S. enterica serotype Kentucky ST198 isolates were 
subjected to WGS with Illumina at GATC Biotech, Germany 
(Illumina HiSeq) (n=45), the Institut Pasteur, France (PF1 
and P2M sequencing platforms, Illumina HiSeq and NextSeq, 
respectively) (n=43), the Technical University of Denmark, 
Denmark (n=7, Illumina MiSeq) or at the Institute for 
Genome Sciences, University of Maryland School of Medi-
cine (IGS-UoM), USA (Illumina HiSeq) (n=2). Paired-end 
reads varied in read length depending on the sequencing 
platform/site, from 100 to 146 bp, yielding a mean of 196-fold 
coverage per isolate (minimum 30-fold, maximum 687-fold) 
(Table S1). Short-read sequences have been deposited at the 
European Nucleotide Archive (ENA) (http://www. ebi. ac. uk/ 
ena), under study accession number PRJNA445436 and the 
genome accession numbers are provided in Table S1.
other genomes studied
Additional S. enterica serotype Kentucky ST198 WGS data 
were obtained from the GenomeTrakr project (https:// ftp- 
trace. ncbi. nih. gov/ pathogen/ Results/ Salmonella) [25, 26]. All 
3014 S. enterica serotype Kentucky isolates in the Salmonella 
project were downloaded from National Center for Biotech-
nology Information on 06/01/2016, and ST was determined 
using srst2 [27]. From the 73 available ST198 GenomeTrakr 
sequences, we excluded those that were missing the source 
information required for our analysis (source, location and 
year of isolation), and retained those from geographical 
regions underrepresented in our own dataset that were 
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non-redundant in terms of source/outbreak (n=24; accession 
numbers in Table S1), bringing the total number of genomes 
analysed in this study to 121.
Sequencing and construction of reference genome 
201001922
Genomic DNA from S. enterica serotype Kentucky ST198 
isolate 201001922 was also sequenced using a hybrid 
sequencing approach at the Institute for Genome Sciences, 
University of Maryland School of Medicine (IGS-UoM), USA, 
as described elsewhere [28]. Paired-end, 3 kb insert libraries 
sequenced on the 454 GS FLX Titanium platform (Roche) 
were combined with paired-end, 300 to 400 bp insert libraries 
sequenced with 100 bp read length on the HiSeq 2000 plat-
form (Illumina). Hybrid assemblies were generated with the 
Celera assembler (http:// wgs- assembler. sourceforge. net/ 
wiki/) based on different ratios of 454 and Illumina sequence 
data, and the outputs were compared with respect to the 
number of resulting scaffolds and total scaffold length. For 
the final assembly, a 27-fold genome coverage of 454 data and 
a 30-fold coverage of Illumina sequence data were combined 
to create a draft genome sequence consisting of 11 scaffolds 
and a total length of 4.86 Mbp.
Contigs and scaffolds from the draft assembly were concat-
enated using a linker sequence ( NNNN NCAC ACAC TTAA 
TTAA TTAA GTGT GTGNNNNN), in order to generate 
continuous ‘pseudochromosomes’. The linker sequence 
contains START and STOP codons in each frame and orien-
tation, to allow the gene finder to call truncated genes at all 
contig ends. Contig orders and orientations within the pseu-
dochromosome were determined based on NUCmer v3.23 
[29] nucleotide sequence comparison to ST152 S. enterica 
serotype Kentucky strain CVM29188 (SL475) as a reference 
genome. Protein-coding and RNA gene predictions and 
functional annotations were carried out with CloVR-Microbe 
[30]. The genome sequence of S. enterica serotype Kentucky 
ST198 isolate 201001922 has been deposited in GenBank 
under the accession number CP028357.
mapping and phylogenomic analysis
Short reads for all 121 S. enterica serotype Kentucky ST198 
isolates were mapped to the reference genome 201001922 
using the mapping pipeline RedDog v1b4 (https:// github. 
com/ katholt/ RedDog) to identify single-nucleotide vari-
ants (SNVs), as previously described [31, 32]. RedDog uses 
Bowtie2 v2.2.3 [33] with the sensitive local method and a 
maximum insert size of 2000 to map all genomes to the refer-
ence genome. SNVs were then identified using SAMtools 
v0.0.19 [34] with a Phred score ≥30, and alleles at each locus 
were determined by comparing to the consensus base in that 
genome, using SAMtools pileup to remove low quality alleles 
(Phred base quality ≤20, read depth ≤5 or a heterozygous 
base call). SNVs were filtered to exclude those present in 
repeat regions, phage regions or the SGI. Gubbins v1 [35] 
was run using default settings to identify and remove SNVs in 
recombinant regions. The final SNV set used for phylogenetic 
analysis consisted of 2066 SNVs.
To estimate a Bayesian phylogeny with divergence dates, 
an alignment of SNV alleles was passed to beast (Bayesian 
Evolutionary Analysis Sampling Trees) v2.4.6 [36], in addi-
tion to isolation dates for each genome. The model param-
eters were as follows: GTR+G substitution model, lognormal 
relaxed clock, constant population size. As the coefficient 
of rate variation parameter was calculated to be 0.57 (95 % 
highest posterior density (HPD) 0.44–0.70), and the distribu-
tion was not abutting zero, a relaxed clock model was favoured 
over a strict clock. The model with a constant population size 
produced higher overall likelihoods compared to a Bayesian 
skyline model, and calculations of changes in population 
size in the skyline model indicated that the population had 
been constant over time, so the simpler model was favoured. 
Five independent beast runs of 100 million iterations were 
combined, representing 450 million Markov chain Monte 
Carlo (MCMC) generations after burn-in removed. Parameter 
estimates were calculated using Tracer v1.6 [37]. A maximum 
clade credibility tree was generated using TreeAnnotator 
v1.7.5 [38]. To test the robustness of the molecular clock 
signal, ten further beast runs with randomized tip dates were 
generated using the same model.
Additional testing of the molecular clock was undertaken by 
constructing a maximum-likelihood phylogeny using RAxML 
v8.1.23 [39], using 100 bootstrap replicates, with the final set 
of SNVs. To check for a molecular clock signal, a linear regres-
sion was performed using the root-to-tip distances from the 
phylogeny with year of isolation. Phylogeographical analysis 
was performed by modelling geographical region (defined by 
the United Nations subregion geoschemes [40]) as a discrete 
trait on the final beast tree, using an empirical Bayes method 
[41] implemented in the  make. simmap function in phytools 
v0.6.44 [42].
Assembly, annotation and pangenome analysis
All reads were filtered using FastXToolKit v0.0.14 [43] to remove 
all reads containing bases called as ‘N’, and Trimmomatic v0.30 
[44] was used to remove any reads with a mean Phred quality 
score below 30. Each isolate genome was assembled using SPAdes 
v3.5 [45] using a kmer range of 21, 33, 55, 65 and 75. Scaffolding 
was performed using SSPACE v3.0 [46] and GapFiller v1.10 
[47] with default settings. All assemblies were ordered against 
the S. enterica serotype Kentucky ST198 strain 201001922 refer-
ence genome using Abacas v1.3.1 [48]. Prokka v1.10 [49] was 
used to annotate each assembly using a preferential protein 
database made up of coding sequences from the 201001922 
reference genome, the ARG-Annot resistance database [50], 
and the SGI1, SGI1-K and SGI2 references (accession numbers 
AF261825, AY463797 and AY963803). Roary v3.6.0 [51] was 
used to determine core and accessory genes for all anno-
tated genomes. Core genes were defined as present in at least 
95 % of genomes.
Identification of resistance, virulence and phage 
genes
AMR gene alleles were determined by mapping short 
reads to the ARG-Annot resistance database [50] using 
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srst2 [27]. AMR gene locations were determined by inter-
rogating genome assemblies with blast v2.3.0 [52]. Asso-
ciations between AMR genes and SGI type or geographical 
regions were determined using two-way contingency tables 
for each gene. Each region was tested with Fisher’s exact test 
to determine whether the frequency of the gene was positively 
associated with that specific region compared to all other 
regions. A P value cut-off of 0.05 was used to determine 
significance.
Presence or absence of Salmonella virulence genes defined 
in the vfdb database [53] was determined using srst2 to 
screen the short-read data. All genomes were screened using 
phaster [54] to detect phage regions.
Reconstruction of SGI sequences
ISMapper v1 [55] and the assembly graph viewer Bandage 
[56] were used to piece together segments of the SGI in each 
genome. To do this, each assembly was queried with blast 
to identify which contigs contained SGI backbone and AMR 
genes. Each assembly was also queried for IS26 using ISMap-
per's assembly improvement mode [55], identifying contigs 
that contained IS26 flanking sequence. Contigs containing 
flanking IS26 sequence with SGI genes or AMR genes were 
hypothesized to be part of the SGI. Both pieces of information 
(blast and ISMapper results) were used in conjunction with 
the reference SGI1-K reference sequence (accession number 
AY463797) to determine which contigs could be joined 
together. In some cases, it was unclear whether IS26-flanked 
AMR genes were located within the SGI or a plasmid. In these 
cases, Bandage was used to examine the assembly graphs and 
determine the paths linking the SGI, IS26 and AMR genes, 
providing additional evidence for contig connection.
IS26 copy number was estimated by mapping all genomes 
to the IS26 sequence using Bowtie v2.2.9 [33], and dividing 
the read depth across IS26 by the mean chromosomal read 
depth. To assess whether IS26 copy number was increasing 
over time within the MDR lineage, a linear regression analysis 
was performed using estimated IS26 copy number and year 
of isolation for each isolate.
Analysis of IncI1 and IncC plasmids
All S. enterica serotype Kentucky ST198 genomes were 
screened for plasmid replicons using srst2 v0.2.0 with the 
version of the PlasmidFinder database [57] that is distrib-
uted in the srst2 package. Reads from S. enterica serotype 
Kentucky ST198 isolates containing IncI1 plasmids as 
well as a set of publicly available IncI1 plasmid sequences 
(Table S2) were mapped to the IncI1 plasmid pNF1358 
(accession number DQ017661). SNVs were called using the 
same method as described above for chromosomal SNVs. 
The resulting SNVs were filtered to include only those that 
were present in core genes (defined as genes present in 
100 % of the IncI1 plasmid sequences, see Table S3). The 
final alignment consisted of 1380 SNVs, which was used 
to create a maximum-likelihood tree with RAxML v8.1.16 
[39] using a GTR+G model with 100 bootstraps. Reads from 
S. enterica serotype Kentucky ST198 isolates containing IncC 
plasmids were typed with srst2 against the cgMLST IncA/C 
plasmid database [58] to determine the 28-locus plasmid 
sequence type (pST) for each plasmid.
RESuLTS
Phylogenetic analysis of S. enterica serotype 
Kentucky ST198
All 121 S. enterica serotype Kentucky ST198 genomes were 
mapped to the draft reference genome for S. enterica serotype 
Kentucky ST198 strain 201001922 (see Methods), and 2066 
SNVs were identified in the core genome. Linear regression of 
root-to-tip distances against year of isolation indicated strong 
temporal structure for all isolates, as did date randomization 
tests in beast (Figs S1 and S2). The alignment of these SNVs 
and the years of isolation were then used to construct a dated 
phylogenetic tree using beast, which was further overlaid 
with region of origin to infer routes of geographical spread 
(see Methods). The results (Fig. 1) indicate that nearly all MDR 
isolates belong to a single monophyletic clade of S. enterica 
serotype Kentucky ST198, which we estimate emerged around 
1989 (95 % HPD 1983–1993) in Egypt (Fig. 1). The beast 
analysis estimated the evolutionary rate to be 4.8×10−7 substi-
tutions per site per year (95 % HPD 5.28×10−7−3.78×10−7 
substitutions per site per year; see Fig. S2). This is equivalent to 
a mean rate of 1.6 SNVs per year, which is similar to rates esti-
mated for other nontyphoidal Salmonella serotypes including 
Typhimurium and Agona [59–61], and faster than those esti-
mated for typhoidal serotypes Typhi and Paratyphi A [62–64].
The MDR clade includes all isolates carrying SGI1-K and 
derived variants, which include all of the CIPR S. enterica 
serotype Kentucky ST198 (Fig.  1; more details below). In 
addition to the SGI, the MDR lineage has accumulated amino 
acid mutations in the QRDR. The first mutation occurred 
circa 1992 in gyrA codon 83 (TCC to TTC, Ser83Phe) (light 
purple, Fig. 1), and was then followed circa 1996 by a muta-
tion in codon 80 of parC (AGC to ATC, Ser80Ile) (pink, 
Fig. 1). These mutations increased MIC for ciprofloxacin, but 
CIPR did not arise until additional mutations in codon 87 of 
gyrA occurred; at least three such mutations were observed 
in the MDR clade (GAC to GGC, AAC or TAC; Asp87Gly, 
Asp87Asn, Asp87Tyr) (dark purple shading, Fig. 1).
The parC-80 and gyrA-87 mutations accompanied a dramatic 
clonal expansion, with the clone spreading from Egypt to 
other geographical locations (Fig. 1). Multiple independent 
transfers of S. enterica serotype Kentucky ST198 out of Egypt 
and Northern Africa are evident, with two clades, carrying 
either Asp87Tyr (TAC) or Asp87Asn (AAC) mutations in 
GyrA codon 87, emerging circa 2000. The former spread into 
East Africa, Middle Africa, South Asia, Europe and Western 
Asia (dark red line, Fig. 1); the latter spread to South-East 
Asia, Europe and West Africa (black line, Fig. 1).
Interestingly, the ST198 genomes isolated from agricultural 
sources in the USA (including 98K, isolated from poultry in 
1937, see Table S1) lack the SGI and gyrA/parC mutations 
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Fig. 1. Phylogeographical analysis of S. enterica serotype Kentucky ST198 based on whole-genome SNV data. Bayesian maximum clade 
credibility tree inferred using beast, with the MDR lineage shaded orange. The dark orange box indicates three isolates from the same 
patient. Major internal nodes are labelled with circles indicating branch support (black, ≥95 % posterior support; red, >70 % posterior 
support; unfilled, >30 % posterior support); divergence date estimates (95 % higher posterior density values) are provided for key points 
in the evolution of the MDR lineage. Leaf nodes are coloured by region of origin (see inset map). Coloured branches indicate inferred 
geographical distribution of internal branches, inferred using maximum-likelihood ancestral trait reconstruction. Data columns indicate 
country of origin; source of isolate (H for human, N for non-human, ? for unknown); SGI type (see inset legend); quinolone resistance-
related codons, with resistance-associated alleles highlighted. Reference genome 201001922 is marked with red arrow. Red and black 
vertical lines indicate clades that are mentioned in the text.
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(Fig. 1). Notably, while these strains were isolated contem-
poraneously with the MDR clade (2003 to 2016) they are 
only distantly related to it, sharing a most recent common 
ancestor (MRCA) circa 1925 (95 % HPD 1898–1938; Fig. 1). 
This finding is consistent with previous work indicating that 
ST198 isolates from livestock or poultry in the USA belong to 
a different genomic cluster (198.1) than MDR ST198 isolates 
from clinical cases (198.2) [7].
Long-term persistence in a single patient
Three S. enterica serotype Kentucky ST198 isolates were 
recovered in consecutive years (2009, 2010 and 2011) from 
the same patient, who had been infected in Egypt (dark orange 
box, Fig. 1). These isolates belonged to the MDR lineage and 
shared an MRCA circa 2005, suggesting persistent coloniza-
tion of ~6 years duration (Fig. 1). The 2011 isolate, 201100664, 
differed the most from the inferred MRCA (30 SNVs; 21 non-
synonymous SNVs, 6 synonymous SNVs, 3 intergenic SNVs), 
yielding an estimated in vivo substitution rate of 5 SNVs per 
year, faster than that estimated by beast analysis of the whole 
data set. Many of the non-synonymous mutations were in 
genes responsible for flagella (n=7) and iron transport (n=2) 
(Table S4), although no motility changes were detected in 
this isolate. Eleven SNVs separated 201000305 and 09–9322 
(8 non-synonymous SNVs, 2 synonymous SNVs, 1 intergenic 
SNV). One of these eleven SNVs was found in another iron 
transport gene (asmbl_3909, Table S4).
SGI in S. enterica serotype Kentucky
The presence of any SGI backbone genes was taken as 
evidence of SGI integration (Fig. S3). The data indicate 
that the SGI has been acquired by S. enterica serotype 
Kentucky ST198 on three distinct occasions, integrating 
each time site-specifically in the 3′-end of the trmE gene. 
SGI2 (previously SGI1-J), which carries the multidrug-
resistance region in a different position of the SGI1 
backbone (Fig. 2a), was present in a single isolate from 
Indonesia, and SGI1-B was present in a single isolate from 
India; both these isolates were distantly related to the main 
MDR lineage (Fig. 1). The vast majority (95 %) of genomes 
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belonging to the main MDR lineage carried the SGI1-K 
subtype or one of its derivatives (SGI1-P or SGI1-Q), 
consistent with acquisition of SGI1-K in the MRCA circa 
1989 in Egypt, shortly before the expansion of the clone 
(Fig. 1). Within this MDR lineage, some isolates had large 
deletions of the SGI backbone (e.g. deletions spanning 
from S011 to S026, or from int to S026), but still retained 
the multidrug-resistance region between trmE and yidY 
(Figs S3 and S4).
Almost every SGI1-positive S. enterica serotype Kentucky 
ST198 isolate in this study had a distinct SGI structure (Figs 2b 
and S4). In addition to large deletions of the SGI backbone, 
some isolates had inversions of whole or part of the resistance 
gene segment of the island, with various deletions and rear-
rangements of the transposons (Fig. 2b). There were multiple 
different IS26 insertion sites within the resistance elements 
of the island, providing evidence that IS26 has mediated the 
majority of differences found in the resistance region of the 
island (Fig. 2b). We found that IS26 was rarely present in 
S. enterica serotype Kentucky ST198 isolates outside of the 
MDR lineage (Fig. S3). Within the MDR lineage, linear 
regression analysis of IS26 copy number against year of isola-
tion showed some evidence of IS26 accumulation over time 
(0.12 IS26 copies per year, P=0.01, R2=0.05) (Fig. S5).
There was no relationship between degraded SGI1s and 
geographical region or country, or between the loss of core 
SGI resistance genes (defined as aacA5, blaTEM-1, sul1 and tetA) 
and region (see Methods). We found that strAB, aphA2, aph3-
Ia, catA1, dfrA12 and mph(A) were present significantly more 
frequently in Egypt compared to all other regions (Table S5).
multidrug-resistance genes and plasmids in  
S. enterica serotype Kentucky ST198
Overall, we found that 35 isolates in the full strain set 
carried at least one plasmid, covering 13 different known 
plasmid incompatibility types (Table S1). Within the MDR 
lineage, there was extensive phenotypic and genotypic 
variation in antimicrobial susceptibility observed (Fig. 3). 
A part of this variability could be attributed to the acqui-
sition of plasmids carrying additional AMR genes, as 32 
isolates in the MDR lineage carried genes outside the SGI 
that are likely plasmid-borne (Fig.  3e). Known plasmid 
replicons were identified in 23 isolates, and in total we iden-
tified eight different plasmid incompatibility types across 
the MDR strain set (C, I1, L/M, Q1, W, X1, X4, Y). From 
these 23 isolates carrying known plasmid incompatibility 
types, we were able to determine precise plasmid–AMR 
gene links for 20 isolates.
There appeared to be no link between geography and plasmid 
type, with plasmids present in isolates from multiple different 
regions (Fig. S6). The majority of genes encoding carbapen-
emases (blaOXA-48 and blaNDM-1), ESBLs (blaCTX-M-1) and cepha-
mycinases (blaCMY-2, blaCMY-4 and blaCMY-16) were carried by either 
IncI1 or IncC (previously IncA/C2) plasmids (Fig. 3d, e). Two 
IncL/M plasmids were found to carry blaOXA-48 or blaCTX-M-15 and 
an IncW plasmid was found to carry blaVIM-2 (Fig. 3d, e). The 
eight isolates resistant to azithromycin contained the mph(A) 
gene. These isolates clustered into two groups. A plasmid loca-
tion of mph(A) was found for four isolates. Three different Inc 
types were identified (IncI1, IncC and IncL/M).
There was little evidence that any plasmids were being main-
tained as the MDR lineage evolved (Fig. 3), although the group 
of three isolates recovered from the same patient in Egypt 
(09–9322, 201000305, 201100664; discussed above) all carried 
IncI1 plasmids. These three plasmids were identical in their core 
gene content, although IncI1 plasmids in 201100664 differed 
from those in the earlier two isolates by two intergenic SNVs 
(Fig. S7). Interestingly, these three isolates all lacked the SGI 
and any other chromosomal resistance genes, and their IncI1 
plasmids differed substantially from one another in resistance 
gene content (Fig. 3e). The two early isolates mostly carried 
resistance genes for aminoglycosides, sulfonamides, trimetho-
prim, phenicols and macrolides. The plasmid in the final isolate, 
201100664, had lost almost all of the resistance genes found in 
the previous two isolates, except for mph(A), and had gained the 
carbapenemase-encoding blaOXA-48 gene. IncI1 plasmids were 
detected in a further six S. enterica serotype Kentucky ST198 
genomes, but these did not cluster in either the IncI1 plasmid 
tree or the chromosome tree, consistent with seven distinct 
introductions of IncI1 plasmids into the S. enterica serotype 
Kentucky ST198 MDR lineage, each associated with distinct 
AMR gene contents (Figs 3 and S7).
Two isolates of the MDR lineage carried IncC plasmids (99–2998 
and 201410673). Both IncC plasmids were genotyped as pST3, 
which is commonly associated with blaCMY [58], and this cepha-
mycinase-encoding gene was found in the plasmid from isolate 
99–2998. Interestingly, the IncC plasmid in isolate 201401673 
was carrying a carbapenemase-encoding blaNDM-1 gene, which 
is more commonly found in pST1 IncC plasmids [58]. This 
blaNDM-1 gene was found in a different structural context to 
the blaNDM genes in the pST1 IncC plasmids; as usual it was 
downstream of ISAba125; however, instead of being upstream 
of ble, it was upstream of qacEΔ1 and sul1, with a remnant of 
the ble gene left behind from the insertion of qacEΔ1 (Fig. S8). 
We found that this blaNDM-1 region was entirely covered by WGS 
reads, with no breaks or gaps in coverage, supporting that it is 
the true structure in this plasmid (Fig. S8). This configuration 
also appears in another pST3 IncC plasmid, pRH-1238, from 
S. enterica serotype Corvallis (GenBank accession number 
KR091911), isolated from a wild bird in Germany [65].
Another source for the phenotypic diversity of S. enterica sero-
type Kentucky ST198 susceptibility profiles was variations in 
the SGI1 (Fig. 3d). Notably, plasmid carriage was significantly 
associated in the cases where SGI1-P, SGI1-Q (containing few 
or no AMR genes) or no SGI were detected (Fisher’s exact test, 
P=0.024, odds ratio=2.65, 95 % confidence interval=1.09–6.64) 
(Fig. 3b, d and e).
Chromosomal gene content diversity amongst  
S. enterica serotype Kentucky ST198 isolates
There was very little gene content diversity evident amongst the 
S. enterica serotype Kentucky ST198 chromosome sequences 
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Fig. 3. Horizontally acquired AMR genes in the S. enterica serotype Kentucky ST198 MDR lineage. (a) Dated Bayesian (beast) phylogeny 
for the MDR lineage, extracted from the tree shown in Fig. 1. Leaf nodes are coloured by region of origin (see the key); the orange box 
highlights three isolates recovered from the same patient over 3 years. (b–e) AMR features of each isolate in the tree. (b) SGI type (see 
the key, dash indicates no SGI detected). (c) AMR phenotypes, indicated as boxes coloured by antimicrobial class (see the key, I in the box 
denotes intermediate resistance). (d) AMR genes located within the SGI1 are indicated with boxes coloured by antimicrobial class (* in 
the box indicates gene is interrupted). (e) Plasmid incompatibility group(s) identified in each genome; AMR genes located within these 
plasmids are printed, coloured by antimicrobial class; genes in brackets are genes for which it was not possible to determine location.
(Fig. S9). Three phages were detected within the reference 
genome 201001922 and these three phage regions, in addition 
to the SGI1, were the only regions to show large differences 
between genomes from the MDR lineage and those from 
other lineages (Fig. S9). Supporting this, within the accessory 
gene content identified using Roary (see Methods), only four 
genes were found to be present exclusively in all but one of the 
MDR lineage genomes. All four of these genes were located 
within a single phage, ST160 (43 kbp, 46 genes, positions 
541864–584944 in the 201001922 reference genome). This 
phage was found to be inserted between ompP and mlaA in 
the MDR lineage. A variation of this phage was also present 
in the oldest genome, 98K, which is outside the MDR lineage; 
however, in this genome the phage was inserted between napB 
and hutI.
Examination of the virulence gene content in all isolates 
revealed that there was no difference between S. enterica sero-
type Kentucky ST198 isolates belonging to the MDR lineage 
and those belonging to other lineages (Fig. S10). Only five 
virulence genes were present in less than 95 % of genomes – 
gogB (0.8 %), sipB (7 %), sipC (35 %), ompD (57 %) and sciQ 
(80 %) (Table S6) – however, these were randomly distributed 
in the tree and not associated with lineage (Fig. S10).
DISCuSSIon
Our data show that nearly all MDR S. enterica serotype Kentucky 
ST198 belong to a single lineage that has accumulated AMR 
determinants since the early 1990s (Fig. 1). It first acquired 
a variant of the SGI1, SGI1-K, which conferred resistance to 
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ampicillin, streptomycin, gentamicin, sulfamethoxazole and 
tetracycline (Fig. 2). The SGI1 structure appears to be highly 
susceptible to genetic rearrangements, with distinct forms found 
in each isolate likely due to the transpositional activity of IS26, 
which resulted in deletion of some or all genes inside SGI1. The 
loss of resistance genes was often made up for by acquisition of 
additional MDR plasmids (Fig. 3).
IS26 is 820 bp long and encodes a single transposase with 
14 bp terminal repeats on each end [66]. Each of the three SGI1 
subtypes found in the MDR lineage carried one or more copies 
of IS26, and all genomes in the MDR lineage carried IS26, with 
no genomes outside of this clade carrying IS26. The recently 
described mechanism used by IS26 to transpose may provide 
an explanation as to why the SGI variants in these isolates are 
so dynamic. During the transposition, IS26 extracts itself from 
the donor DNA molecule, as well as DNA lying upstream of it 
between itself and another IS26 element, and uses this to form a 
translocatable unit [67]. It then finds another IS26 element in the 
receiving DNA molecule, and inserts itself as well as the excised 
donor DNA next to it, forming a tandem array of IS26s in direct 
orientation [67]. This model illustrates that IS26 is likely the 
causative agent for many of the deletions, inversions and trans-
positions within the SGI, eventually resulting in the genesis of 
the different SGI1 variants (SGI1-K, SGI1-P and SGI1-Q) seen 
in this dataset (Fig. 2).
Whilst the origin of the MDR clade appears to be intimately 
linked with the acquisition of the SGI1 in Egypt, it is the QRDR 
triple-mutant CIPR subclade that disseminated globally (Fig. 1). 
Ciprofloxacin resistance is infrequent in Salmonella [68], and 
we hypothesize that this high-level resistance is linked to strong 
selective pressure exerted by fluoroquinolone use in poultry, 
S. enterica serotype Kentucky’s main reservoir [69]. This resist-
ance might also have come at no cost to the fitness of the bacte-
rial cell, as has been shown in close relatives S. enterica serotype 
Typhi and Escherichia coli [70, 71].
During its spread around the world, the S. enterica serotype 
Kentucky ST198 MDR lineage became more resistant by the 
additional acquisition of various AMR plasmids, carrying genes 
encoding resistance to newer drugs, including third-generation 
cephalosporins, carbapenems and azithromycin. These genes 
were acquired locally around the Mediterranean basin with 
no subsequent clonal expansion. Interestingly, the two isolates 
containing IncC plasmids did not carry the SGI. This observation 
is supported by many studies in the literature that have described 
the incompatibility of the SGI and IncC plasmids, as they share 
the same regulatory system [14, 72, 73].
In this study, we were unable to detect any other non-AMR 
related genes that could explain the clonal success of the MDR 
lineage. Examination of phage, pseudogenes and known viru-
lence genes did not reveal any significant differences between 
the MDR lineage and other S. enterica serotype Kentucky ST198 
genomes, although this does not rule out the possibility of more 
subtle variants contributing to virulence such as the regulatory 
SNV recently described for invasive S. enterica serotype Typh-
imurium ST313 [74].
In conclusion, WGS analysis of S. enterica serotype Kentucky 
ST198 has significantly expanded our knowledge of the evolu-
tion and dissemination of MDR variants of this important 
pathogen. Previously, as this lineage was emerging, MLST 
and PFGE were used in combination [2, 3] for this purpose; 
however, the diversity of PFGE types of CIPR S. enterica serotype 
Kentucky ST198 isolates precluded any fine-scale or long-term 
analysis of S. enterica serotype Kentucky ST198 dissemination, 
which our data shows was likely due to noise introduced by IS26 
activity. The population structure uncovered here should serve 
as a useful framework with which to understand and track the 
ongoing evolution of the MDR lineage of S. enterica serotype 
Kentucky ST198, which our data clarifies is a globally dissemi-
nated clone capable of rapid spread and further accumulation 
of last-line AMR determinants.
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